Topics:
Pediatric Oncology • Hematology • Pediatric Hematology • Benign Hematology • bleeding disorders
In which platelet function disorders would you consider use of Novoseven as opposed to platelet transfusion?
Are there particular clinical scenarios that would affect your decision?
Answer from: at Academic Institution
There are now two recombinant activated factor VII (rFVIIa) available in the US. Trade names are NovoSeven RT and SEVENFACT. NovoSeven RT is US FDA approved for use in Glanzmann thrombasthenia. There are case reports of its efficacy in off label use for other inherited platelet function defects. SEV...
Sign in or Register to read more